What question did this study set out to answer?

This review aims to integrate the CXCR4/CXCL12 and CXCR5/CXCL13 pathways and evaluate the role of STAT3 in CLL.

STAT3 as a Candidate Shared Regulator of the CXCR4/CXCL12 and CXCR5/CXCL13 Homing Axes in Chronic Lymphocytic Leukemia

View Full Paper

Ask AI

Bookmark

Authors

Review evaluates STAT3 integration in CXCR4 and CXCR5 homing axes in CLL, indicating potential therapeutic strategies.

This review aims to integrate the CXCR4/CXCL12 and CXCR5/CXCL13 pathways and evaluate the role of STAT3 in CLL.
Reviewed literature on CXCR4/CXCL12 and CXCR5/CXCL13 signaling in CLL.
Analyzed the role of cytokines such as IL-6, IL-10, and IL-21 in the homing process.
Proposed therapeutic strategies based on the integrated pathway.
Identified STAT3 as a key regulator linking CXCR4 and CXCR5 chemokine pathways.
Highlighted circulating CXCL13 as a prognostic biomarker in CLL.
Noted that STAT3 inhibition may counteract stromal-mediated protection of CLL cells.

Aviwe Ntsethe (2026) studied this question.

View Full Paper

Ask AI

Bookmark